1. Bidirectional research on the efficacy of traditional Chinese medicine, sponsored by National Natural Science Foundation, 22-24, RMB 17,. Yuan,

2. Evaluation of vascular endothelial cell function of patients before and after PTCA and its clinical significance, sponsored by Hubei Science and Technology Research Plan, RMB 2,. Yuan,

3.Ananadamide's research on it. The special scientific research fund for doctoral programs in colleges and universities, 24-26, 6, yuan, presided over

4. The research and development of raloxifene, a second-class national drug, was sponsored by the National Science and Technology Research Plan, which was 1 million yuan from 23 to 26. 5. Pharmacodynamics of Shengxuesu Oral Liquid, Hubei Science and Technology Department, 25-2.